¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"myeloid cell"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
myeloid cell
°ñ¼ö¼¼Æ÷
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
agnogenic myeloid metaplasia
¿øÀκҸí°ñ¼öÈ»ý
myeloid
°ñ¼ö¸ð¾ç-, °ñ¼ö¼º
myeloid metaplasia
°ñ¼öÈ»ý
acantholytic cell
°¡½Ã¼¼Æ÷ºÐ¸®¼¼Æ÷
angioimmunoblastic T-cell lymphoma
Ç÷°ü¸é¿ª¸ð±¸T¼¼Æ÷¸²ÇÁÁ¾
annular elastotic giant cell granuloma
°í¸®Åº·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾, ȯ»óź·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾
accessory cell
º¸Á¶¼¼Æ÷, µ¡¼¼Æ÷
antibody-dependent cell-mediated cytotoxicity
Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
antibody-producing cell
Ç×ü»ý»ê¼¼Æ÷
antibody-screening cell
Ç×ü¼±º°Ç÷±¸
antigen-presenting cell
Ç׿øÁ¦½Ã¼¼Æ÷
antigen-reactive cell
Ç׿ø¹ÝÀÀ¼¼Æ÷
antigen-recognizing cell
Ç׿øÀÎÁö¼¼Æ÷
argentaffin cell
ÀºÄ£È¼¼Æ÷
argyrophilic cell
ÀºÄ£È¼¼Æ÷
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
sickle cell anemia
³´ÀûÇ÷±¸ºóÇ÷
cell
¼¼Æ÷
accessory cell
º¸Á¶¼¼Æ÷, µ¡¼¼Æ÷
acinar cell
»ù²Ê¸®¼¼Æ÷
amacrine cell
¹«Ãà»è¼¼Æ÷
balloon cell
dz¼±¼¼Æ÷
basal cell
¹Ù´Ú¼¼Æ÷, ±âÀú¼¼Æ÷
basal cell carcinoma
¹Ù´Ú¼¼Æ÷¾ÏÁ¾, ±âÀú¼¼Æ÷¾ÏÁ¾
basket cell
¹Ù±¸´Ï¼¼Æ÷
basophilic cell
È£¿°±â¼¼Æ÷
beta cell
º£Å¸¼¼Æ÷
bipolar cell
µÎ±Ø¼¼Æ÷
blood cell
Ç÷¾×¼¼Æ÷, Ç÷±¸
ethmoidal cell
¹úÁý»À¹úÁý
eukaryotic cell
ÁøÇÙ¼¼Æ÷
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
myeloid cell
(¢¡marrow cell) °ñ¼ö¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
agnogenic myeloid metaplasia
¿øÀκҸí°ñ¼öÈ»ý
myeloid
°ñ¼ö¸ð¾ç-
myeloid metaplasia
°ñ¼öÈ»ý
acantholytic cell
°¡½Ã¼¼Æ÷ÇØ¸®¼¼Æ÷
accessory cell
º¸Á¶¼¼Æ÷, µ¡¼¼Æ÷
acidophilic cell
È£»ê¼º¼¼Æ÷
acinar cell
»ù²Ê¸®¼¼Æ÷
acinic cell carcinoma
»ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
amacrine cell
¹«Ãà»è¼¼Æ÷
ameboid cell
¾Æ¸Þ¹Ù¸ð¾ç¼¼Æ÷
annular elastotic giant cell granuloma
°í¸®Åº·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾, ȯ»óź·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾
antibody-dependent cell-mediated cytotoxicity
Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
antibody-producing cell
Ç×ü»ý»ê¼¼Æ÷
antibody-screening cell
Ç×ü¼±º°Ç÷±¸
antigen-presenting cell
Ç׿øÀü´Þ¼¼Æ÷
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
agnogenic myeloid metaplasia
¿øÀκҸíÀÇ °ñ¼öÈ»ýÁõ.
agnogenic(idiopathic) myeloid metaplasia
¿øÀκҸí(Ư¹ß¼º) °ñ¼öÈ»ýÁõ(ê«ì×ÝÕÙ¥ ÍéâÐûùßæñø)
immature myeloid element
¹Ì¼÷°ñ¼ö¼º Ç÷__¡ÍéâÐàõúìϹ).
immature myeloid element
¹Ì¼÷°ñ¼ö¼º Ç÷±¸(?ËËàËÛÌ´Ë´).
NK cell [=natural killer cell]
ÀÚ¿¬»ì»ó¼¼Æ÷
alpha cell glucagon cell
¾ËÆÄ¼¼Æ÷ ±Û·çÄ«°ï¼¼Æ÷
quiescent cell, Q cell
Á¤Áö¼¼Æ÷
A cell
A ¼¼Æ÷
B cell
B¼¼Æ÷(~ á¬øà)
B cell
B ¼¼Æ÷
B cell
B ¼¼Æ÷.
B cell antigen
B ¼¼Æ÷Ç׿ø
B cell differentiation factor (BCDF)
B¼¼Æ÷ ºÐÈÀ¯¹ßÀÎÀÚ
B cell growth factor
B ¼¼Æ÷¼ºÀåÀÎÀÚ
B cell growth factor (BCGF)
B¼¼Æ÷ Áõ½ÄÃËÁøÀÎÀÚ
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
2
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
myeloid cell
°ñ¼ö¼¼Æ÷(¡á¬øà).
myeloid cell
°ñ¼ö¼¼Æ÷(?ËṴ̂).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
extramedullary myeloid cell tumor
°ñ¼ö¿Ü°ñ¼ö¼¼Æ÷Á¾
agnogenic myeloid metaplasia
¿øÀκҸíÀÇ °ñ¼öÈ»ýÁõ.
agnogenic(idiopathic) myeloid metaplasia
¿øÀκҸí(Ư¹ß¼º) °ñ¼öÈ»ýÁõ(ê«ì×ÝÕÙ¥ ÍéâÐûùßæñø)
aleukemic myelosis=myelofibrosis with myeloid metaplasia
¹«¹éÇ÷¼º °ñ¼öÁõ
immature myeloid element
¹Ì¼÷°ñ¼ö¼º Ç÷±¸(?ËËàËÛÌ´Ë´).
immature myeloid element
¹Ì¼÷°ñ¼ö¼º Ç÷__¡ÍéâÐàõúìϹ).
leukemia,myeloid, chronic
¸¸¼º °ñ¼ö¼º(Ø·àõ ÍéâÐàõ)
mature myeloid element
¼º¼÷°ñ¼ö¼º Ç÷±¸(?ËËàËÛÌ´Ë´).
mature myeloid element
¼º¼÷°ñ¼ö¼º Ç÷±¸(¡ÍéâÐàõúìϹ).
myelofibrosis with myeloid metaplasia
°ñ¼ö¾çÈ»ý(åÆûùßæ)°ñ¼ö¼¶À¯Áõ
myeloid
°ñ¼ö¾ç(ËËàËâ)ÀÇ.
myeloid antigen
°ñ¼ö¾ç(ÍéâÐåÆ) Ç׿ø
myeloid element
°ñ¼ö¼º Ç÷±¸(¡àõúìϹ).
myeloid element
°ñ¼ö¼º Ç÷±¸(?ËÛÌ´Ë´).
myeloid leukemia
°ñ¼ö¼º ¹éÇ÷º´(?ËÛËÑÌ´ËÓ).
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½